We are live on ! Find out more
ACA

Atlas Capital Advisors Portfolio holdings

AUM $875M
This Fund
S&P 500
This Quarter Est. Return
-0.06%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$788M
AUM Growth
+$132M
Cap. Flow
+$145M
Cap. Flow %
18.42%
Top 10 Hldgs %
24.98%
Holding
991
New
89
Increased
169
Reduced
295
Closed
64

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$47.4M
2
MSFT icon
Microsoft
MSFT
+$18M
3
PLMR icon
Palomar
PLMR
+$9.13M
4
AAPL icon
Apple
AAPL
+$8.46M
5
AMZN icon
Amazon
AMZN
+$8.26M

Sector Composition

Rank Sector Weight
1 Technology 12.56%
2 Consumer Staples 8.01%
3 Financials 7.27%
4 Healthcare 4.4%
5 Consumer Discretionary 4.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UHS icon
251
Universal Health Services
UHS
$10.5B
$440K 0.06%
2,451
-1,916
-44% -$390K
IBN icon
252
ICICI Bank
IBN
$108B
$440K 0.06%
14,726
+4,240
+40% +$128K
PSO icon
253
Pearson
PSO
$9.9B
$439K 0.06%
27,218
-711
-3% -$10.6K
CCL icon
254
Carnival Corporation Ltd
CCL
$39.7B
$437K 0.06%
+17,529
New +$410K
SNX icon
255
TD Synnex
SNX
$20.2B
$437K 0.06%
3,724
+130
+4% +$15.6K
ZBH icon
256
Zimmer Biomet
ZBH
$18.4B
$436K 0.06%
4,126
+3,960
+2,386% +$425K
ALL icon
257
Allstate
ALL
$67.5B
$435K 0.06%
2,258
-36
-2% -$6.99K
PSX icon
258
Phillips 66
PSX
$81.4B
$435K 0.06%
3,820
-582
-13% -$74K
SCHE icon
259
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
$431K 0.05%
16,167
+201
+1% +$5.67K
AVY icon
260
Avery Dennison
AVY
$13.4B
$430K 0.05%
+2,300
New +$469K
RSP icon
261
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
$430K 0.05%
2,452
+1,000
+69% +$181K
RSPH icon
262
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$784M
$427K 0.05%
14,565
+1
+0% +$31
FMS icon
263
Fresenius Medical Care
FMS
$12.9B
$423K 0.05%
18,688
+2,412
+15% +$52.4K
XCEM icon
264
Columbia EM Core ex-China ETF
XCEM
$2B
$423K 0.05%
14,275
-398
-3% -$12.6K
HMY icon
265
Harmony Gold Mining
HMY
$12.3B
$418K 0.05%
50,966
-957
-2% -$9.29K
DBX icon
266
Dropbox
DBX
$8.12B
$415K 0.05%
13,822
+12,982
+1,545% +$358K
OUSA icon
267
ALPS O'Shares U.S. Quality Dividend ETF
OUSA
$762M
$413K 0.05%
7,783
+400
+5% +$21.7K
CRH icon
268
CRH
CRH
$66.8B
$412K 0.05%
4,450
-225
-5% -$21.7K
FANG icon
269
Diamondback Energy
FANG
$52.7B
$409K 0.05%
2,498
STLD icon
270
Steel Dynamics
STLD
$37.6B
$406K 0.05%
3,563
-104
-3% -$13.8K
CFG icon
271
Citizens Financial Group
CFG
$30.6B
$398K 0.05%
9,088
-90
-1% -$3.98K
MOMO
272
Hello Group
MOMO
$866M
$397K 0.05%
51,494
-5,336
-9% -$37.9K
FENY icon
273
Fidelity MSCI Energy Index ETF
FENY
$1.94B
$393K 0.05%
16,482
-700
-4% -$17.5K
AMLP icon
274
Alerian MLP ETF
AMLP
$13.1B
$392K 0.05%
8,141
TMO icon
275
Thermo Fisher Scientific
TMO
$220B
$389K 0.05%
747

Similar funds

Atlas Capital Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Atlas Capital Advisors held 991 positions worth $788M, up 20% from $656M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Atlas Capital Advisors deployed $145M of net new capital in Q4 2024, opening 89 new positions and adding to 169 existing holdings. Its largest new stake was Arhaus: 223,512 shares worth $2.1M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 10% a quarter earlier, followed by Consumer Staples and Financials.

On the sell side, the largest reduction was Vanguard FTSE Europe ETF, an estimated $2.8M trimmed.

  • Atlas Capital Advisors's largest Q4 2024 buy was Arhaus: 223,512 shares worth $2.1M.
  • Atlas Capital Advisors added most to Procter & Gamble in Q4 2024, an estimated $47.4M increase.
  • Atlas Capital Advisors's biggest Q4 2024 reduction was Vanguard FTSE Europe ETF, cutting an estimated $2.8M.
  • Atlas Capital Advisors fully exited Banc of California in Q4 2024, selling an estimated $546K.
  • Atlas Capital Advisors's ten largest holdings make up 25% of its $788M portfolio in Q4 2024.
  • Atlas Capital Advisors opened 89 new positions and closed 64 in Q4 2024.
  • Atlas Capital Advisors's portfolio value rose 20% quarter-over-quarter to $788M.

Based on Atlas Capital Advisors's 13F filing for Q4 2024, filed 12 Feb 2025.